The Economic Impact of Medetomidine on Critical Care Utilization: A Longitudinal Analysis of Intensive Care Unit Charges for Opioid Withdrawal Across the Adulterated Era
Listen to this summary
The authors aimed to quantify the economic impact of the adulterated fentanyl supply, particularly focusing on the effects of xylazine and medetomidine, on critical care utilization for opioid withdrawal treatment. Their longitudinal analysis revealed a significant increase in ICU charges and admissions associated with opioid withdrawal as medetomidine became prevalent, highlighting a substantial public health challenge that may necessitate changes in health system resource allocation and withdrawal protocols.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of addiction medicine
View all →May 11, 2026 · Journal of addiction medicine
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis
May 11, 2026 · Journal of addiction medicine
Prolonged Fentanyl Detection on Urine Drug Testing: A Case for Revising Interpretation Frameworks in the Setting of Chronic Use
May 11, 2026 · Journal of addiction medicine
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder
May 6, 2026 · Journal of addiction medicine
The Scientific Debate on Khat Addiction: Evidence Across Humans, Animals, and Policy Domains
May 6, 2026 · Journal of addiction medicine
Maternal Opioid-related Diagnosis in Pregnancy and Risk of Adverse Perinatal Outcomes
May 6, 2026 · Journal of addiction medicine
Methadone and Torsades de Pointes: A Case Series
More in Internal Medicine
View all →May 11, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Cytokine Profiling of Systemic Sclerosis-related Pulmonary Hypertension
May 11, 2026 · JAMA
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
